Infinium Pharmachem Complete Financial Statements
INFINIUM • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Infinium Pharmachem (INFINIUM).
Downloads include all available records across all periods.
For market performance, see the
INFINIUM stock price today
.
Profitability Ratios
Net Profit Margin
5.06%
2025 data
EBITDA Margin
12.03%
2025 data
Operating Margin
11.00%
2025 data
Return on Assets
4.04%
2025 data
Return on Equity
6.40%
2025 data
Balance Sheet Ratios
Current Ratio
14.00
2025 data
Debt to Equity
1.58
2025 data
Equity Ratio
63.13%
2025 data
Asset Turnover
0.80
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+130.2%
Year-over-Year
Equity Growth
+108.3%
Year-over-Year
Liabilities Growth
+130.2%
Year-over-Year
Operating Cash Flow Growth
-680.0%
Year-over-Year
Investing Cash Flow Growth
-575.0%
Year-over-Year
Financing Cash Flow Growth
+1480.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 158 | 137 | 116 | 100 |
| Expenses | 0 | 139 | 117 | 98 | 89 |
| EBITDA | 0 | 19 | 20 | 17 | 11 |
| Operating Profit Margin % | 0.00% | 11.00% | 14.00% | 14.00% | 10.00% |
| Depreciation | 0 | 3 | 3 | 1 | 1 |
| Interest | 0 | 4 | 2 | 3 | 2 |
| Profit Before Tax | 0 | 12 | 15 | 13 | 9 |
| Tax | 0 | 4 | 4 | 3 | 2 |
| Net Profit | 0 | 8 | 12 | 10 | 7 |
| Earnings Per Share (₹) | 0.00 | 5.60 | 10.61 | 6.82 | 60.07 |
Related Pages for Infinium Pharmachem
Additional stock information and data for INFINIUM
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 198 | 86 | 71 | 59 |
| Current Assets | 140 | 65 | 51 | 44 |
| Fixed Assets | 24 | 20 | 19 | 4 |
| Capital Work in Progress | 1 | 0 | 0 | 9 |
| Investments | 29 | 0 | 0 | 0 |
| Other Assets | 144 | 66 | 52 | 46 |
| LIABILITIES | ||||
| Total Liabilities | 198 | 86 | 71 | 59 |
| Current Liabilities | 10 | 8 | 10 | 14 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 125 | 60 | 24 | 14 |
| Share Capital | 16 | 14 | 5 | 1 |
| Reserves & Surplus | 94 | 45 | 18 | 12 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | -29 | 5 | 9 | 12 | 7 | 3 |
| Investing Activities | -27 | -4 | -5 | -7 | -5 | -1 |
| Financing Activities | 79 | 5 | -3 | -2 | -1 | -1 |
| Net Cash Flow | 23 | 6 | 1 | 4 | 1 | 1 |